AIM ImmunoTech, Inc. (AIM)
0.1626
-0.01
(-4.35%)
USD |
NYAM |
Oct 22, 16:00
0.1626
0.00 (0.00%)
After-Hours: 16:15
AIM ImmunoTech Price to Book Value : 0.6087 for Oct. 22, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 21, 2026 | 0.6364 |
| October 20, 2026 | 0.6222 |
| October 19, 2026 | 0.6106 |
| October 16, 2026 | 0.6293 |
| October 15, 2026 | 0.6375 |
| October 14, 2026 | 0.6057 |
| October 13, 2026 | 0.636 |
| October 12, 2026 | 0.6641 |
| October 09, 2026 | 0.6738 |
| October 08, 2026 | 0.6723 |
| October 07, 2026 | 0.6843 |
| October 06, 2026 | 0.6832 |
| October 05, 2026 | 0.7113 |
| October 02, 2026 | 0.6738 |
| October 01, 2026 | 0.7027 |
| September 30, 2026 | 0.6551 |
| September 29, 2026 | 0.6495 |
| September 28, 2026 | 0.6903 |
| September 25, 2026 | 0.7116 |
| September 24, 2026 | 0.7611 |
| September 23, 2026 | 0.7861 |
| September 22, 2026 | 0.8071 |
| September 21, 2026 | 0.7843 |
| September 18, 2026 | 0.7768 |
| September 17, 2026 | 0.8135 |
| Date | Value |
|---|---|
| September 16, 2026 | 0.7936 |
| September 15, 2026 | 0.7996 |
| September 14, 2026 | 0.8344 |
| September 11, 2026 | 0.8299 |
| September 10, 2026 | 0.8494 |
| September 09, 2026 | 0.873 |
| September 08, 2026 | 0.8599 |
| September 04, 2026 | 0.852 |
| September 03, 2026 | 0.8749 |
| September 02, 2026 | 0.8782 |
| September 01, 2026 | 0.8835 |
| August 31, 2026 | 0.846 |
| August 28, 2026 | 0.9673 |
| August 27, 2026 | 0.9359 |
| August 26, 2026 | 0.9359 |
| August 25, 2026 | 0.9509 |
| August 24, 2026 | 0.9509 |
| August 21, 2026 | 0.9673 |
| August 20, 2026 | 0.9475 |
| August 19, 2026 | 0.8917 |
| August 18, 2026 | 0.8756 |
| August 17, 2026 | 0.9097 |
| August 14, 2026 | 0.8232 |
| August 13, 2026 | 0.9681 |
| August 12, 2026 | 0.9621 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.675 |
| Alnylam Pharmaceuticals, Inc. | 22.45 |
| Anika Therapeutics, Inc. | 2.049 |
| Savara, Inc. | 6.491 |
| Vericel Corp. | 5.944 |
Price to Book Value Related Metrics
| PS Ratio | 11.40 |
| Price | 0.1626 |
| Earnings Yield | -2.36K% |
| Market Cap | 4.714M |